Ixekizumab in nail psoriasis

Dermatol Ther. 2020 May;33(3):e13352. doi: 10.1111/dth.13352. Epub 2020 Apr 9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents* / adverse effects
  • Humans
  • Nail Diseases* / chemically induced
  • Nail Diseases* / diagnosis
  • Nail Diseases* / drug therapy
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • ixekizumab